{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:17:06Z","timestamp":1790626626673,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.08.018","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T12:49:18Z","timestamp":1157028558000},"page":"414-423","source":"Crossref","is-referenced-by-count":60,"title":["Preparation and immunogenic properties of a recombinant West Nile subunit vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Michael M.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Corpuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Martyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth-Ann","family":"Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Tesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Siirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Travassos da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Weeks-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.08.018_bib1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMo020128","article-title":"West Nile virus encephalitis","volume":"347","author":"Petersen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.08.018_bib2","unstructured":"CDC West Nile Virus website: Statistics, Surveillance, and Control. http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/surv&controlCaseCount06_detailed.htm."},{"key":"10.1016\/j.vaccine.2006.08.018_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/S1020-49892006000200006","article-title":"West Nile virus activity in Latin America and the Caribbean","volume":"19","author":"Komar","year":"2006","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2006.08.018_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999, results of a household-based seroepidemiological survey","volume":"358","author":"Mostashari","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.08.018_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3201\/eid0704.010414","article-title":"Clinical characteristics of the West Nile fever outbreak in Israel","volume":"7","author":"Chowers","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"9130","key":"10.1016\/j.vaccine.2006.08.018_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(98)03538-7","article-title":"West Nile encephalitis epidemic in southeastern Romania","volume":"352","author":"Tsai","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.08.018_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3201\/eid0701.010118","article-title":"Outbreak of West Nile virus infection, Volgograd region, Russia, 1999","volume":"7","author":"Platonov","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.018_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3201\/eid0704.010401","article-title":"West Nile virus: a reemerging global pathogen","volume":"7","author":"Petersen","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.018_bib9","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of Dengue Virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib10","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib11","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib12","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.018_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","article-title":"Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.018_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2001.tb02703.x","article-title":"Flavivirus DNA vaccines","volume":"951","author":"Chang","year":"2001","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.vaccine.2006.08.018_bib16","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2006.08.018_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005013343254","article-title":"West Nile virus vaccine","volume":"1","author":"Monath","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.vaccine.2006.08.018_bib18","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib19","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","article-title":"A recombinant envelope protein vaccine against West Nile virus","volume":"23","author":"Ledizet","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.018_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/vim.2000.13.401","article-title":"A live attenuated WNV strain as a potential veterinary vaccine","volume":"13","author":"Lustig","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib21","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"issue":"18","key":"10.1016\/j.vaccine.2006.08.018_bib22","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2006.08.018_bib23","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/CDLI.8.6.1150-1155.2001","article-title":"Use of recombinant envelope proteins for serological diagnosis of dengue virus infection in an immunochromatographic assay","volume":"8","author":"Cuzzubbo","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.08.018_bib24","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6872","key":"10.1016\/j.vaccine.2006.08.018_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.08.018_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.154.3.1287","article-title":"Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones","volume":"154","author":"Livingston","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI118964","article-title":"Dominant recognition by human CD8+ cytotoxic T lymphocytes of Dengue virus nonstructural proteins NS3 and NS1.2a","volume":"98","author":"Mathew","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2006.08.018_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","article-title":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice","volume":"192","author":"Schlesinger","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.08.018_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc\u03b3 receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib31","unstructured":"Watts DM, Tesh RB, Siirin M, da Rosa AT, Newman PC, Clements DE, et al. Durable efficacy of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine, in press."},{"key":"10.1016\/j.vaccine.2006.08.018_bib32","first-page":"353","article-title":"Cell lines derived from late embryonic stages of Drosophila melanogaster","volume":"27","author":"Schneider","year":"1972","journal-title":"J Embryol Exper Morphol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1101\/gad.3.6.882","article-title":"Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells","volume":"3","author":"Johansen","year":"1989","journal-title":"Genes Dev"},{"key":"10.1016\/j.vaccine.2006.08.018_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nbt0291-173","article-title":"Regulated expression allows high level production and secretion of HIV gp120 envelope glycoprotein in Drosophila Schneider cells","volume":"9","author":"Culp","year":"1991","journal-title":"Bio\/technology"},{"key":"10.1016\/j.vaccine.2006.08.018_bib35","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.08.018_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0264-410X(95)00105-A","article-title":"Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix","volume":"13","author":"Ronnberg","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.018_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.010420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.018_bib38","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.018_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0091-6749(96)80146-1","article-title":"Update on cytokines","volume":"97","author":"Borish","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2006.08.018_bib41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc\u03b3 receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:48:15Z","timestamp":1683571695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06009480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06009480"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}